Risk Factors and Outcomes According to Age at Transplantation with an HLA-identical Sibling for Sickle Cell Disease

Saenz C, Tisdale J . Assessing Costs, Benefits, and Risks in Chronic Disease: Taking the Long View. Biol Blood Marrow Transplant. 2015; 21(7):1149-50. DOI: 10.1016/j.bbmt.2015.03.007. View

De Montalembert M, Brousse V, Chakravorty S, Pagliuca A, Porter J, Telfer P . Are the risks of treatment to cure a child with severe sickle cell disease too high?. BMJ. 2017; 359:j5250. DOI: 10.1136/bmj.j5250. View

Shenoy S, Angelucci E, Arnold S, Baker K, Bhatia M, Bresters D . Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant.... Biol Blood Marrow Transplant. 2017; 23(4):552-561. DOI: 10.1016/j.bbmt.2017.01.009. View

Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini M . Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014; 99(5):811-20. PMC: 4008115. DOI: 10.3324/haematol.2013.099747. View

Dampier C, LeBeau P, Rhee S, Lieff S, Kesler K, Ballas S . Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol. 2011; 86(2):203-5. PMC: 3554393. DOI: 10.1002/ajh.21905. View

DeBaun M, Ghafuri D, Rodeghier M, Maitra P, Chaturvedi S, Kassim A . Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis. Blood. 2018; 133(6):615-617. PMC: 6367648. DOI: 10.1182/blood-2018-10-880575. View

Maitra P, Caughey M, Robinson L, Desai P, Jones S, Nouraie M . Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe. Haematologica. 2017; 102(4):626-636. PMC: 5395103. DOI: 10.3324/haematol.2016.153791. View

Tshilolo L, Tomlinson G, Williams T, Santos B, Olupot-Olupot P, Lane A . Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa. N Engl J Med. 2018; 380(2):121-131. PMC: 6454575. DOI: 10.1056/NEJMoa1813598. View

Arnold S, Brazauskas R, He N, Li Y, Aplenc R, Jin Z . Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica. 2017; 102(11):1823-1832. PMC: 5664386. DOI: 10.3324/haematol.2017.169581. View

10.

Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M . Survival in adults with sickle cell disease in a high-income setting. Blood. 2016; 128(10):1436-8. DOI: 10.1182/blood-2016-05-716910. View

11.

Bernaudin F, Verlhac S, Peffault de Latour R, Dalle J, Brousse V, Petras E . Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia. JAMA. 2019; 321(3):266-276. PMC: 6439675. DOI: 10.1001/jama.2018.20059. View

12.

King A, Shenoy S . Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia. Blood. 2014; 123(20):3089-94. DOI: 10.1182/blood-2013-01-435776. View

13.

Ware R, De Montalembert M, Tshilolo L, Abboud M . Sickle cell disease. Lancet. 2017; 390(10091):311-323. DOI: 10.1016/S0140-6736(17)30193-9. View

14.

Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J . Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2016; 129(11):1548-1556. PMC: 5356458. DOI: 10.1182/blood-2016-10-745711. View